What must Japan fix before offering permanent heart pumps?
The authors argue that a permanent heart pump should not be rolled out in Japan until doctors can legally switch it off at a patient's request and patients are helped, not forced, to plan for the end of life.
Source
Matters to address prior to introducing new life support technology in Japan: three serious ethical concerns related to the use of left ventricular assist devices as destination therapy and suggested policies to deal with them
Study at a glance
- Design
- Qualitative / archival — Normative ethical analysis drawing on published guidelines, Japanese law and survey reports; no new data.
- N
- No participants; the authors state they used only published literature.
- Population
- Patients with end-stage heart failure who are ineligible for transplant and might receive a left ventricular assist device as destination therapy in Japan.
- Outcome
- Thesis that Japan must legalise and protect withdrawal of the device, support voluntary advance directives and justify selection criteria before wide adoption.
Structured fields used in claim comparison tables when every cited study has a complete layer.
What they did
The authors review Western and Japanese guidelines on destination therapy, a heart pump implanted permanently in patients who cannot get a transplant. They identify three ethical problem areas in the Japanese setting: switching the device off, advance directives, and choosing which patients receive it. They then propose policy responses and answer objections based on Japanese cultural attitudes.
What they found
They argue that because Japanese law gives no clear protection to doctors who withdraw life support, deactivation may be practically impossible even when patient, family and doctors agree, risking prolonged and miserable deaths. They warn that demanding advance directives as a condition of treatment would turn a right into an obligation, yet few Japanese people prepare them. They also argue that a strong sanctity-of-life culture and low cost-consciousness would erode selection criteria, while an age cut-off at 65 is hard to justify because the device is not scarce. They call for a basic patient-rights act guaranteeing the right to refuse treatment, legally binding advance directives, immunity for proper withdrawal and conscientious objection.
The limits
What it doesn't show
This is an argument, not a study: predictions about how doctors and families will behave are the authors' expectations, supported by a few surveys and anecdotes rather than data collected on destination therapy itself. The analysis is specific to Japanese law and culture, so its conclusions do not transfer directly elsewhere. The authors themselves concede that changing deep-rooted attitudes through explanation alone may be idealistic, and they do not settle whether age-based rationing is discrimination.
Key terms
- Destination therapy
- Permanent implantation of a heart pump in patients with end-stage heart failure who cannot receive a transplant.
- Left ventricular assist device (LVAD)
- A mechanical pump that helps the heart's main pumping chamber move blood around the body.
- Advance directive
- A document in which a person states in advance what treatment they do or do not want if they later lose decision-making capacity.
- Advance care planning
- An ongoing conversation among patient, family and clinicians about goals and future treatment.
- Sanctity of life vs quality of life
- The view that life should be preserved regardless of condition, contrasted with weighing how good a life is for the person living it.
- Killing vs letting die
- The distinction the authors rely on to argue that stopping life support lets the underlying disease cause death rather than killing the patient.
Flashcards
0 of 10 answers reviewed
Research intelligence for this paper
See its role on concept claims, tensions it is part of, placement history, and related discoveries.
Quiz yourself
What is destination therapy?
Common questions
Isn't switching off a heart pump the same as killing the patient?
The authors, following Western guidelines, argue it is withdrawal of treatment: the patient dies of the underlying heart disease, and competent patients have a right to refuse burdensome treatment.
Why not just require every patient to write an advance directive?
Because that turns a right into an obligation, may be coercive, and clashes with cultural taboos about discussing death; the authors want directives encouraged and explained, not demanded.
Why is a strict age limit questionable here but not for organ transplants?
Donor organs are scarce, but heart pumps can be manufactured on demand, so scarcity cannot justify excluding older patients.
More on End-of-life ethics